Table 2.
Test | Test method | Criteria |
---|---|---|
Purity | DTZ staining is used for islet identity, which is visualized by qualified personnel | ≥30% |
Viability | Fluorescent dye (FDA and PI) staining is used for islet viability, which is determined by qualified personnel | ≥70% |
Islet yield | DTZ staining is used for islet identity and islet number is counted by qualified personnel | First transplant: ≥5,000 IEQ/kg RBW Second transplant: ≥10,000 IEQ/kg RBW |
Transplant tissue volume | Centrifuge and measure packed cell volume in conical tube | ≤10 mL |
Microbiological test | Gram stain on 100 μL smear with microscopic examination by qualified personnel | No intact organism observed |
Endotoxin content | QCL-1000 Chromogenic LAL Test Kit, Cat number 50-647U, (BioWhittaker, Inc.) | ≤5 EU/kg body weight of the potential recipient |
Glucose static incubation | In vitro insulin release in 1.6 mM and 16.7 mM glucose. Expressed by SI | ≥1.5 |
DTZ: dithizone.
FDA: fluorescein diacetate, for live cells.
PI: propidium iodide, for dead cells.
RBW: recipient body weight.
SI: stimulation index.